Enrica Capelletto

Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis

M. Duruisseaux, Anna Martínez‐Cardús, María Eréndira Calleja-Cervantes et al. · The Lancet Respiratory Medicine · 2018 · 222 citations · Full text

Medicine, Oncology, Epigenetics +16

Crizotinib in <i>MET</i> -Deregulated or <i>ROS1</i> -Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo et al. · Clinical Cancer Research · 2019 · 186 citations · Full text

Medicine, Oncology, Pharmacology +16

L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR -Mutated NSCLC

Melissa Bersanelli, Roberta Minari, Paola Bordi et al. · Journal of Thoracic Oncology · 2016 · 166 citations · Full text

Medicine, Medicinal Chemistry, Oncology +15

Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal

Giuseppe Pelosi, Mauro Papotti, Luisella Righi et al. · Journal of Thoracic Oncology · 2018 · 39 citations · Full text

Medicine, Oncology, Pathology +16

Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma

Joanna Kopecka, Iris C. Salaroglio, Luisella Righi et al. · Lung Cancer · 2018 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +14